Corcept Therapeutics has achieved a significant milestone with the U.S. Food and Drug Administration (FDA) granting approval for its selective…
Read More
Science News: Empowering Public Understanding of Science, Medicine, and Technology Since 1921
Science News, a venerable institution in the realm of science journalism, has been a steadfast beacon of accurate and accessible…
Read More
A Breakthrough Food Supplement Could Reverse Alarming Decline of Honeybees
A groundbreaking food supplement, developed by a collaborative team of researchers led by the University of Oxford, promises to offer…
Read More
TWiV 1284: Clinical update with Dr. Daniel Griffin
In a post-New Year’s Day recording, Dr. Daniel Griffin and Vincent Racaniello of This Week in Virology (TWiV) provided a…
Read More
Ludwig Cancer Research Unveils Dual-Inhibitor Strategy to Combat Acute Myelogenous Leukemia by Overcoming Cellular Differentiation Blockade
The landscape of hematological oncology is facing a potential paradigm shift following a landmark study by Ludwig Cancer Research, which…
Read More
Eli Lilly’s Triple Agonist Retatrutide Achieves Remarkable 16.8% Weight Loss in Phase 3 Trial for Type 2 Diabetes
Eli Lilly and Company has announced groundbreaking results from a Phase 3 clinical trial for its investigational triple agonist, retatrutide,…
Read More
ADHD brains show sleep-like activity even while awake
A groundbreaking study published in the Journal of Neuroscience (JNeurosci) has unveiled critical insights into the neurological underpinnings of attention-deficit/hyperactivity…
Read More
University of Manchester Scientists Spearhead Discovery of New Subatomic Particle at CERN Large Hadron Collider
In a landmark achievement for the field of high-energy physics, researchers from The University of Manchester have played a pivotal…
Read More
LinkedIn Report Unveils Critical Skills Driving the Future of Clinical Laboratory Careers Amidst Evolving Healthcare Landscape
A groundbreaking analysis from LinkedIn’s latest "Skills on the Rise" report has cast a revealing light on the rapidly transforming…
Read More
Daiichi Sankyo and Tempus AI collaborate on ADC clinical development
In a significant move poised to accelerate the innovation pipeline for antibody-drug conjugate (ADC) therapies, Japanese pharmaceutical giant Daiichi Sankyo…
Read MoreYOU MAY HAVE MISSED
